Z4J-15471-35592
4 vaccinations
9 coded responses
49 check-ins
8 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 26-30
- ZIP prefix
- 077 / NJ
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Registered in v-safe
-
2021-03-18
Dose 1 — Pfizer-BioNTech
-
2021-03-18
Survey response — day 0, dose 1MedDRA: Palpitations — Feeling: GoodFree text: Palpitations in heartMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-19
-
2021-03-20
Survey response — days 1–6 daily, dose 1MedDRA: Heart rate increased, Palpitations — Feeling: GoodFree text: Palpitations and 115 BPM heart rate ( ECG reading)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-04-01
-
2021-04-08
Dose 2 — Pfizer-BioNTech
- 2021-04-08
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
-
2021-04-22
Survey response — day 14, dose 2MedDRA: Gout, Pre-existing disease — Feeling: FairFree text: Left foot - Gout flare-up. Early stages at this time. May not be related to vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-01
- 2021-05-06
- 2021-05-14
- 2021-05-20
- 2021-07-08
- 2021-10-07
-
2021-10-25
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-25
-
2021-10-26
Survey response — days 1–6 daily, dose 3MedDRA: Gout, Pre-existing disease — Feeling: Fair · Site: Pain · Chills · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Gout flare-upMedDRA releases: 2024-11 · check-in free text available
- 2021-10-27
- 2021-10-28
- 2021-10-29
- 2021-10-30
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2021-12-06
-
2022-01-24
Survey response — 3 months, dose 3MedDRA: Diarrhoea, Gout, Inflammation, Nasopharyngitis, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Symptoms of Common Cold (two weeks ago, PCR Saliva test concluded negative result.) Gout Flare-Up of Left Foot (inflammation, as of January 21, 2022. Ongoing as of writing.) Nothing else otherwise.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-25
Survey response — 6 months, dose 3MedDRA: Blood pressure increased, Heart rate increased, Impaired work ability, Loss of personal independence in daily activities, Pain in extremity, Peripheral swelling — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Swollen foot, alternating, and foot pain lasting for two months, ended last week. In duration, could neither work nor partake in normal activities. Two episodes of high blood pressure, elevated heart rate lasting for nearly an entire day.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-25
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-09-09
Dose 4 — Pfizer-BioNTech
- 2022-09-09
- 2022-09-10
- 2022-09-11
-
2022-09-12
Survey response — days 1–6 daily, dose 4MedDRA: Headache, Migraine, Pyrexia — Feeling: GoodFree text: YESTERDAY: Feverish, Headache/Migraine. Side effects ended overnight.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-18
Survey response — day 7, dose 4MedDRA: Unevaluable event — Feeling: GoodFree text: Possible skin condition developing (like ringworm.) Going to doctor tomorrow to straighten out.MedDRA releases: 2024-11 · check-in free text available
- 2022-09-23
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-12-09
-
2023-03-10
Survey response — 6 months, dose 4MedDRA: Visual impairment, Vitreous floaters — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | |
| 2 | 2021-04-08 | Pfizer-BioNTech | |
| 3 | 2021-10-25 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-09 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-25 | Successful 2022-04-26 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Palpitations in heart
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Palpitations and 115 BPM heart rate ( ECG reading)
Release 7 — day 14, dose 2
Symptoms: Left foot - Gout flare-up. Early stages at this time. May not be related to vaccine.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Gout flare-up
Release 11 — 3 months, dose 3
Symptoms: Symptoms of Common Cold (two weeks ago, PCR Saliva test concluded negative result.) Gout Flare-Up of Left Foot (inflammation, as of January 21, 2022. Ongoing as of writing.) Nothing else otherwise.
Release 11 — 6 months, dose 3
Symptoms: Swollen foot, alternating, and foot pain lasting for two months, ended last week. In duration, could neither work nor partake in normal activities. Two episodes of high blood pressure, elevated heart rate lasting for nearly an entire day.
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): YESTERDAY: Feverish, Headache/Migraine. Side effects ended overnight.
Release 12 — day 7, dose 4
Systemic reaction (other): Possible skin condition developing (like ringworm.) Going to doctor tomorrow to straighten out.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood pressure increased | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Gout | ✓ | ✓ | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Impaired work ability | · | · | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Loss of personal independence in daily activities | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Peripheral swelling | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Visual impairment | · | · | ✓ |
| SD | Vitreous floaters | · | · | ✓ |
| SRO | Gout | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Migraine | · | · | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Pyrexia | · | · | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release